Ignite Creation Date:
2025-12-24 @ 12:41 PM
Ignite Modification Date:
2025-12-27 @ 9:58 PM
Study NCT ID:
NCT01409161
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2011-08-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-10-05
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12-18
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-18
Completion Date Type:
ESTIMATED
First Submit Date:
2011-08-02
First Submit QC Date:
None
Study First Post Date:
2011-08-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-11
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED